Noubar Afeyan

$1.89 B

Ranked #2141 in World

About Noubar Afeyan

Noubar Afeyan, born in Beirut in 1962 and now a U.S. citizen residing in Lexington, Massachusetts, boasts a multifaceted career as a serial entrepreneur, inventor, and academic. Afeyan, who graduated from McGill University and earned a Ph.D. from MIT, has authored numerous scientific papers and holds over 100 patents. He is the founder and CEO of Flagship Pioneering and the chairman of Moderna, having co-founded or significantly contributed to over 50 life science startups. Beyond his business endeavors, Afeyan actively engages in philanthropy, significantly impacting sectors like education, community development, and humanitarian aid, particularly in Armenia. His efforts in academia, business, and philanthropy have earned him widespread recognition, including the Ellis Island Medal of Honor and several other prestigious awards. Afeyan's commitment to science and community epitomizes his diverse contributions to global innovation and societal betterment.

Born

July 25, 1962 in Beirut, Lebanon

Age

63 years

Source Of Wealth

Biotech

Industries

Healthcare

Citizenship

United States

Residence

Lexington, Massachusetts

Education

Ph.D, Massachusetts Institute of Technology; Bachelor of Science, McGill University

Spouse

Anna Gunnarson

Children

Noubar Afeyan was born in 1962 in Beirut, Lebanon, to Armenian parents. He survived the Armenian genocide and later graduated from Loyola High School in Montreal in 1978. Afeyan went on to earn a B.Eng. in chemical engineering from McGill University in 1983 and a Ph.D. in biochemical engineering from MIT in 1987.

Noubar Afeyan: Family

Afeyan is married to Anna Gunnardottir, a Swedish-born engineer, and they have four children. The family resides in Lexington, Massachusetts.

Noubar Afeyan: Career Highlights

Afeyan started his first biotechnology company in 1987 and has since co-founded or helped build over 50 life science and technology startups. He is the founder and CEO of Flagship Pioneering, a venture capital company focused on biotechnology, and co-founded Moderna (formerly ModeRNA Therapeutics) in 2009, where he currently serves as chairman.

Noubar Afeyan: Companies

Afeyan has been involved with numerous companies throughout his career, including:

Flagship Pioneering
Moderna
PerSeptive Biosystems
Celera Genomics
Applera

Noubar Afeyan: Major Achievements

Afeyan has made significant contributions to the field of biotechnology and entrepreneurship. He has authored numerous scientific papers, patented over 100 inventions, and co-founded or helped build over 50 life science and technology startups. Afeyan is also known for his philanthropic efforts, including co-founding the Initiatives for Development of Armenia (IDeA) and the Aurora Humanitarian Initiative.

Noubar Afeyan: Awards & Achievements

Afeyan has received numerous awards and recognitions for his work, including the Ellis Island Medal of Honor, the Armenian Prime Minister's Commemorative Medal for Patriotic Activities, the Technology Pioneer award from the World Economic Forum, and the Medal of Services to the Motherland. He was also recognized as one of four immigrants leading the efforts to find a vaccine for COVID-19 in 2020.

Noubar Afeyan: Personal Life & Legacy

Afeyan became a U.S. citizen in 2008 and is actively involved in various philanthropic and civic organizations. He sits on the boards of the MIT Corporation, Boston Symphony Orchestra, and Armenian General Benevolent Union (AGBU).

Afeyan is also a founding angel of the Foundation for Armenian Science and Technology (FAST) and the Future Armenian public initiative.

Noubar Afeyan: Trivia

Afeyan is a polyglot and speaks Armenian, English, French, and Russian. He is also a licensed pilot and enjoys flying.

Wealth History

Timeline

1962

Born in Beirut, Lebanon to Armenian parents.

1978

Graduated from Loyola High School in Montreal.

1983

Earned a B.Eng. in chemical engineering from McGill University.

1987

Earned a Ph.D. in biochemical engineering from MIT.

1987

Started his first biotechnology company.

1988

Founded PerSeptive Biosystems, served as its CEO.

2000

Founded Flagship Pioneering, a venture capital company focused on biotechnology.

2000-2016

Senior lecturer at MIT Sloan School of Management.

2001

Launched the "Armenia 2020" initiative, expanded to 2031.

2008

Became a U.S. citizen.

2008

Ellis Island Medal of Honor.

2008

Co-founded the National Competitiveness Foundation of Armenia.

2009

Co-founded Moderna (formerly ModeRNA Therapeutics), currently serves as its chairman.

2012

Armenian Prime Minister's Commemorative Medal for Patriotic Activities.

2012

Technology Pioneer award, World Economic Forum.

2014

Medal of Services to the Motherland.

2015

Co-founded the Aurora Humanitarian Initiative, including The 100 Lives initiative and the Aurora Prize for Awakening Humanity.

2016

Called on the Armenian government to adopt new development strategies.

2016

Great Immigrants Recipient, Carnegie Corporation of New York.

2018

Congratulated Nikol Pashinyan on being elected Armenia's prime minister.

2020

Confirmed that the Canadian government pre-ordered the Moderna vaccine.

2020

Recognized as one of four immigrants leading the efforts to find a vaccine for COVID-19.

2020

Discussed the COVID-19 pandemic with Armenian president Armen Sarkissian.

2020

Wrote a letter to the editor of The New York Times calling for US intervention in the 2020 Nagorno-Karabakh war.

2020

Lecturer at Harvard Business School.

2021

Lebanon's Order of Merit.

2021

Bloomberg New Economy Catalyst.

2021

Met with Pashinyan in Yerevan.

2022

Honorary Doctor of Science, honoris causa (D.Sc.) from McGill University.

2022

Honorary doctorate degree from Yerevan State University.

2023

Called on US politicians and judges to stop questioning established science.

Noubar Afeyan : FAQs

What is Noubar Afeyan's current net worth?

Noubar Afeyan's current net worth is $1.89 billion.

What is Noubar Afeyan's current global rank among billionaires?

Noubar Afeyan holds the 2141st position globally among billionaires.

What is Noubar Afeyan's current ranking within the United States?

Noubar Afeyan holds the 700th position in United States.

What was the change in Noubar Afeyan's net worth compared to the previous year?

Noubar Afeyan's net worth increased by 40.04 million dollars compared to the previous year 2025, when his net worth was 1.85 billion dollars.

What are Noubar Afeyan's main sources of wealth?

Noubar Afeyan's main source of income comes from Biotech.

In which industry does Noubar Afeyan primarily operate?

Noubar Afeyan is primarily involved in the Healthcare industry.

What is Noubar Afeyan educational background?

Noubar Afeyan holds a Ph.D from Massachusetts Institute of Technology and a Bachelor of Science from McGill University.

How old is Noubar Afeyan?

Noubar Afeyan is 63 years old.

Who is Noubar Afeyan and what is his background?

Noubar Afeyan, born in 1962 in Beirut, Lebanon to Armenian parents, is a prominent biotechnology innovator and entrepreneur. He survived the Armenian genocide heritage, graduated from Loyola High School in Montreal in 1978, earned a B.Eng. in chemical engineering from McGill University in 1983, and obtained a Ph.D. in biochemical engineering from MIT in 1987. Afeyan became a U.S. citizen in 2008, is married with four children, and resides in Lexington, Massachusetts.

What are Noubar Afeyan's contributions to academia and his patent achievements?

Noubar Afeyan has made significant contributions to academia and innovation, authoring numerous scientific papers and patenting over 100 inventions. He served as a senior lecturer at MIT Sloan School of Management from 2000 to 2016 and as a lecturer at Harvard Business School since 2020. He received an honorary doctorate degree from Yerevan State University in 2022.

How has Noubar Afeyan impacted the business world, particularly in biotechnology?

Noubar Afeyan has had a profound impact on the biotechnology sector, founding his first company in 1987 and co-founding or developing over 50 start-ups, including Moderna in 2009, where he currently serves as chairman. He is the Founder and CEO of Flagship Pioneering since 2000 and holds over 2 million shares in Moderna. Afeyan announced in 2021 that Moderna would not enforce its COVID-19 vaccine patents during the pandemic.

Can you list Noubar Afeyan's philanthropic efforts?

Noubar Afeyan is actively involved in philanthropy, sitting on the boards of the MIT Corporation, Boston Symphony Orchestra, and Armenian General Benevolent Union. He co-founded several initiatives aimed at the development of Armenia and the Armenian diaspora, including the Initiatives for Development of Armenia, the Armenia 2020 initiative, the Aurora Humanitarian Initiative, and was a founding angel of the Foundation for Armenian Science and Technology.

What role has Noubar Afeyan played in politics and social issues?

Noubar Afeyan has engaged with political and social issues, notably calling on the Armenian government to adopt new development strategies, discussing COVID-19 strategies with Armenian officials, and advocating for US intervention in the Nagorno-Karabakh war in 2020. He also emphasized the importance of science in policy-making, and congratulated Nikol Pashinyan on becoming Armenia's prime minister in 2018.